BackAchilles Therapeutics Plc Overview

Achilles Therapeutics Plc Goodwill

Track Achilles Therapeutics Plc's goodwill ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Goodwill
$0.00

Peer average / median

Loading

Achilles Therapeutics Plc Goodwill History

Loading

Achilles Therapeutics Plc vs. peers: Goodwill Comparison

Loading

Achilles Therapeutics Plc Goodwill Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Achilles Therapeutics Plc (ACHL) FAQ

Achilles Therapeutics Plc (ACHL) currently reports a goodwill of $0 as of September 2024. In the prior-year period, the figure was $0. Use the charts on this page to explore Achilles Therapeutics Plc's goodwill history and peer comparisons.

Achilles Therapeutics Plc's goodwill changed from $0 to $0 (period ending September 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Achilles Therapeutics Plc reported $0 in goodwill as of September 2024. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current goodwill of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Achilles Therapeutics Plc, and consider following ACHL for alerts when major investors trade the stock.

Achilles Therapeutics Plc is classified in the Healthcare sector. On goodwill, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ACHL with unrelated industries.